[1] Nho RS, Hergert P. FoxO3a and disease progression[J].World J Biol Chem, 2014, 5(3):346-354. [2] van Grevenynghe J, Cubas RA, DaFonseca S, et al. FoxO3a:an integrator of immune dysfunction during HIV infection[J]. Cytokine Growth Factor Rev, 2012, 23(4/5):215-221. [3] Karadedou CT, Gomes AR, Chen J, et al. FOXO3a represses VEGF expression through FOXM1 dependent and independent mechanisms in breast cancer[J]. Oncogene, 2012, 31(14):1845-1858. [4] Zheng T, Lu Y. Changes in SIRT1 expression and its downstream pathways in age-related cataract in humans[J]. Curr Eye Res, 2011, 36(5):449-455. [5] Kim BC. FoxO3a mediates transforming growth factor-beta1-induced apoptosis in FaO rat hepatoma cells[J].BMB Rep,2008, 41(10):728-732. [6] Ozaki I, Hamajima H, Matsuhashi S, et al.Regulation of TGF-β1 induced Pro-apoptotic signaling by growth factor receptors and extracellular matrix receptor integrins in the liver[J]. Front Physil, 2011, 2:78. [7] Behzad H, Jamil S, Denny TA, et al. Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines:investigations of the role of Fasin apoptosis due to cytokine starvation[J].Cytokine,2007, 38(2):74-83. [8] Yoon HE, Kim SJ, Kim SJ, et al.Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction:the role of PI3K-Akt-FoxO3a signaling[J]. J Korean Med Sci,2014,29(2):230-237. [9] Im J, Hergert P, Nho RS. Reduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices[J]. Am J Physiol Lung Cell Mol Physiol,2015,309(6):L552-L561. [10] Nho RS,Peterson M,Hergert P,et al.FoxO3a(Forkhead BoxO3a) deficiency protects idiopathic pulmonary fibrosis(IPF) fibroblasts from type Ⅰ polymerized collagen matrix-induced apoptosis via caveolin-1(cav-1) and Fas[J]. PLoS One,2013,8(4):e61017. [11] Zhang M, Lee SJ, An C, et al. Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis[J]. Free Radic Biol Med,2011, 50(10):1252-1262. [12] Chuang PY, Cai W, Li X, et al. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice[J]. Am J Physiol Renal Physiol,2017,313(3):F621-F628. [13] Oellerich MF, Potente M. FOXOs and sirtuins in vascular growth, maintenance, and aging[J]. Circ Res, 2012, 110(9):1238-1251. [14] Yang C, Cao, Zhang Y, et al.Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway[J]. J Transl Med,2015,13:355. [15] Yaku K, Okabe K, Nakagawa T.NAD metabolism:Implications in aging and longevity[J]. Ageing Res Rev,2018,47:1-17. [16] Lu Q, Zhai Y, Cheng Q, et al. The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy[J]. Exp Physiol, 2013, 98(8):934-945. [17] Busso N, Karababa M, Nobile M, et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD[J]. PLoS One, 2008,3(5):e2267. [18] Jin X, Wei Y, Xu F,et al. SIRT1 promotes formation of breast cancer through modulating Akt activity[J]. J Cancer,2018,9(11):2012-2023. [19] Sun W, Li Y, Wei S. miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis[J]. Exp Ther Med, 2018,15(1):1119-1128. [20] Frazzi R, Valli R, Tamagnini I, et al. Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation[J]. Int J Cancer,2013, 132(5):1013-1021. [21] Lalmansingh AS, Karmakar S, Jin Y, et al. Multiple modes of chromatin remodeling by Forkhead box proteins[J]. Biochim Biophys Acta, 2012, 1819(7):707-715. [22] Logan RW, Parekh PK, Kaplan GN. NAD+ cellular redox and SIRT1 regulate the diurnal rhythms of tyrosine hydroxylase and conditioned cocaine reward[J]. Mol Psychiatry,2018, doi:10.1038/s41380-018-0061-1. [23] Hu Q, Wang G, Peng J, et al. Knockdown of SIRT1 suppresses bladder cancer cell proliferation and migration and induces cell cycle arrest and antioxidant response through FOXO3a-mediated pathways[J]. Biomed Res Int, 2017,2017:3781904. |